Brand name authorized in: Cyprus
The drug AFEKSIN contains one active pharmaceutical ingredient (API):
Fluoxetine is a selective inhibitor of serotonin reuptake, and this probably accounts for the mechanism of action. Fluoxetine has practically no affinity to other receptors such as α1, α2, and β-adrenergic; serotonergic; dopaminergic; histaminergic1; muscarinic; and GABA receptors.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows: